ID   BIU-87
AC   CVCL_6881
SY   BIU87
DR   KCB; KCB 2006103YJ
DR   Wikidata; Q28658473
RX   PubMed=9594332;
RX   PubMed=23618585;
RX   PubMed=26116706;
RX   PubMed=30967374;
CC   Problematic cell line: Misidentified/contaminated. Seems to be contaminated by non-human cells (PubMed=26116706). Originally thought to originate from a 58 year old male patient with an urinary bladder carcinoma.
CC   Doubling time: 36 hours (PubMed=9594332); 25.30 +- 0.04 hours (PubMed=30967374).
OX   NCBI_TaxID=32644; ! Unidentified (Unknown organism)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
RX   PubMed=9594332; DOI=10.5555/cmj.0366-6999.110.03.p167.01;
RA   Guo H.-Q., Lu G.-C., Xiong X.-L., Dong J.-H., Liu S.-C., Zao S.-Y.;
RT   "Establishment of doxorubicin-resistant human bladder cancer cell line
RT   (BUI-87/ADMR) and its mechanism of multidrug resistance.";
RL   Chin. Med. J. 110:167-172(1997).
RX   PubMed=23618585; DOI=10.1016/j.juro.2013.04.053;
RA   Zhou H.-L., Zheng Y.-J., Cheng X.-Z., Lv Y.-S., Gao R., Mao H.-P.,
RA   Chen Q.;
RT   "Intercellular transfer of P-glycoprotein from the drug resistant
RT   human bladder cancer cell line BIU-87 does not require cell-to-cell
RT   contact.";
RL   J. Urol. 190:1069-1075(2013).
RX   PubMed=26116706; DOI=10.1096/fj.14-266718;
RA   Ye F., Chen C.-G., Qin J., Liu J., Zheng C.-Y.;
RT   "Genetic profiling reveals an alarming rate of cross-contamination
RT   among human cell lines used in China.";
RL   FASEB J. 29:4268-4272(2015).
RX   PubMed=30967374; DOI=10.1242/bio.041889;
RA   Cheng X.-Z., Zhou H.-L., Tang S.-X., Jiang T., Chen Q., Gao R.,
RA   Ding Y.-L.;
RT   "Intercellular transfer of P-glycoprotein mediates the formation of
RT   stable multi-drug resistance in human bladder cancer BIU-87 cells.";
RL   Biol. Open 8:bio041889.1-bio041889.6(2019).